ideaXme

Ira Pastor, ideaXme life sciences ambassador and founder of Bioquark, interviews, Naveen Jain, M.B.A, BS, Founder and CEO at Viome as well as founder of several companies including Moon Express, Viome, Bluedot, TalentWise, Intelius and InfoSpace.

Ira Pastor comments: On this ideaXme episode, we are going to head back towards the theme of the human micro-biome, which represents the estimated 100 trillion aggregate of all microbiota (bacteria, fungi, protists, viruses, etc. ) that reside on, within, or symbiogenically as part of the human body, and their downstream effects on human health, wellness, and longevity.

Naveen Jain Believes in Using Food as Medicine:

Naveen Jain is a philanthropist, technology pioneer and entrepreneur, driven to solve global grand challenges through innovation. He is the founder of several successful companies including Moon Express, Bluedot, TalentWise, Intelius and InfoSpace, and Viome, which is the topic of today's episode. Viome is focused on disrupting healthcare with the goal of “making illness elective”, by identifying microbial bio-markers that are predictive of chronic diseases, and adjusting the microbial imbalance through personalized nutrition, in essence making illness truly a matter of choice, and not a matter of bad luck, using foods as a medicine.

Personalized Healthcare:

Through Biotech and AI Mr. Jain is also director of the board at the Singularity University where he is focused on educating and inspiring leaders to address humanity’s grand challenges through innovative technologies. Mr. Jain is a director of the board at the XPRIZE Foundation where he is focused on using incentive prizes to find solutions to many of the societal challenges and recently launched a million-dollar Women Safety XPRIZE to empower women around the world. He has been awarded numerous honors for his entrepreneurial successes including, but not limited to, the “Ernst & Young Entrepreneur of the Year”, the “Albert Einstein Technology Medal” for pioneers in technology, the “Ellis Island Medal of Honor”, and the "Most Creative Person” award by Fast Company.

In addition to Viome, on the life sciences/biotech front, Mr. Jain is in the process of setting up an incentive prize challenge to develop “Digital Doctor” (AI based expert system) to improve access to primary care physicians around the world. He is also exploring ways to develop a neurometric system to create better learners and to develop neuroscience based multi-sensory video games that are effective and additive to teach students skills like math, science and history. Mr. Jain is also a strong believer that we should be doing a lot more on the synthetic biology front, creating living bio-factories to reduce global shortages of food, and use microbes to help with cleaning water and generating energy from plentiful resources like ocean water.

On this ideaXme episode, we will hear from Mr. Jain about:

His background, how he developed an interest in engineering, and about his info-tech business success in the "pre-Viome" era. Why he made the jump into the risky biotech industry. Viome's business model, products, and services. Viome's collaboration with the Mayo Clinic on AI-driven personalized nutritional strategies to help understand sleep and obesity. Viome's collaboration with GlaxoSmithKline (GSK) to develop vaccine-based therapies to help prevent and treat chronic diseases. The state of the biotechnology financing world. His Moon Express initiatives.

This interview is in American English

Credits: Ira Pastor interview video, text, and audio.

Follow Ira Pastor on Twitter: @IraSamuelPastor If you liked this interview, read our interview with Dr. Michael Lustgarten!

Follow ideaXme on Twitter: @ideaxm On Instagram: @ideaxme Find ideaXme across the internet including on iTunes, SoundCloud, Radio Public, TuneIn Radio, I Heart Radio, Google Podcasts, Spotify and more.

ideaXme is a global podcast, creator series and mentor programme. Our mission: Move the human story forward!™ ideaXme Ltd.

Ira Pastor, ideaXme life sciences ambassador, interviews Dr. Thupten Jinpa, Ph.D. the Founder and Chairman of Compassion Institute, and the principal author of Compassion Cultivation Training.

Ira Pastor Comments:

"Compassion" is broadly defined as sympathetic pity and concern for the sufferings or misfortunes of others, involves allowing ourselves to be both 1) moved by the suffering and 2) experience the motivation to help alleviate and prevent it.

Dr. Thupten Jinpa:

Dr. Thupten Jinpa, Ph.D. the Founder and Chairman of Compassion Institute, and the principal author of Compassion Cultivation Training, the Institute’s flagship compassion education offering, developed while Dr. Jinpa was at Stanford University, which integrates insights and techniques from psychology, neuroscience, and contemplative practice. Dr. Jinpa trained as a monk at the Shartse College of Ganden Monastic University, South India, where he received the Geshe Lharam degree. Jinpa also holds a B.A. in philosophy and a Ph.D. in religious studies, both from Cambridge University. Dr. Jinpa is also extremely well known for his public role has been the principal English translator to His Holiness The Dalai Lama, spiritual leader of Tibetan Buddhism, since 1985, and has translated and collaborated on numerous books by the Dalai Lama including the New York Times Bestsellers "Ethics for the New Millennium" and "The Art of Happiness", as well as “Towards a True Kinship of Faiths: How the World’s Religions Can Come Together.” Dr. Jinpa’s own publications include works in Tibetan, English translations of classical Tibetan texts, and books, “Self, Reality, and Reason in Tibetan Philosophy,” “Dispelling the Darkness: A Jesuit’s Quest for the Soul of Tibet” and “A Fearless Heart: How the Courage to be Compassionate Can Transform Our Lives.” Dr. Jinpa's latest book is “Tsongkhapa: A Buddha in the Land of Snows,” a modern biography of one of Tibet's greatest masters released in November for the 600th anniversary of his nirvana.

A frequent speaker at various international conferences on mindfulness, compassion, and contemplative practice, Dr. Jinpa also serves as an adjunct professor at the Faculty of Religious Studies at McGill University, Montreal and is the founder and president of the Institute of Tibetan Classics. He has been a core member of the Mind and Life Institute and its Chairman of the Board since January 2012.

On this ideaXme show we will hear from Dr. Jinpa about:

His background and about the definition of compassion and how it is connected with happiness. About Compassion Cultivation Training. The application of compassion meditation towards intervention in chronic pain and stress reduction. About the application of compassion meditation towards improving longevity / healthspan. The Dalai Lama's views on fighting Coronavirus With Compassion. About the Dalai Lama's thoughts on transhumanist topics such as Robotics, Artificial Intelligence and Aging / Life Extension.

Credits: Ira Pastor interview video, text, and audio. Follow Ira Pastor on Twitter:@IraSamuelPastor

If you liked this interview, be sure to check out ourinterview ondeath, dying, and dreams!

Follow ideaXme on Twitter:@ideaxm On Instagram:@ideaxme Find ideaXme across the internet including on ideaXme's YouTube Channel, iTunes,SoundCloud,Radio Public,TuneIn Radio,I Heart Radio, Google Podcasts, Spotify and more.

ideaXme is a global podcast, creator series and mentor programme. Our mission: Move the human story forward!™ ideaXme Ltd.

Ira Pastor, ideaXme life sciences ambassador and founder of Bioquark, interviews, Dr. Marcus Remmers, PhD, Chief Technology Officer at DSM.

Ira Pastor comments:

As we continue upon our core themes of health, wellness, and longevity, amongst the unique aging demographic shifts occurring in the coming decades, we can’t overlook the importance of the global chemicals industry in coming up with novel solutions for the world's population. Central to the modern world economy, the global chemicals industry comprises a $4 trillion industry which converts a variety of raw materials into more than 70,000 different products. Holistic Health Life sciences chemicals (about 30% of the dollar output of the chemistry business) include a wide variety of differentiated chemical and biological substances, pharmaceuticals, diagnostics, animal health products, vitamins, and agricultural products. Speciality chemicals, representing another 10%, are a broad range of higher value materials used on the basis of their performance or function, and may include, but are not limited to such classes as adhesives, colors, fragrances, industrial gases, lubricants, paints, polymers, and surfactants. Royal DSM, commonly known as DSM, is a Dutch multinational active in the fields Nutrition, Health and Sustainable Living. Headquartered in the Netherlands, DSM employs over 21,000 people, in approximately 50 countries, and has annual sales of around €9 billion.

Dr. Marcus Remmers:

We’re honored today to be joined by Dr. Marcus Remmers, Chief Technology Officer at DSM, who is responsible for DSM’s global Science and Technology portfolio. Dr. Remmers graduated in Chemistry at the Universities of Münster and Freiburg, completed his Doctorate Thesis at the Max-Planck-Institute for Polymer Chemistry in Mainz, and did post graduate research at Stanford, Caltech and Cambridge.

Dr. Remmers has strong knowledge and experience in polymer and life sciences R&D, business operations, business development, strategy and change management. Dr. Remmers started his career with Hoechst/Intervet in several managerial roles. In 2001, he joined Merial Ltd. (the animal health division of Merck, and then Sanofi), where he had roles in Business Development, Country Management, Project and Portfolio Management and R&D in Pharma and Biologics. In April 2017, Dr. Remmers became Chief Technology Officer of DSM, where he works to secure the company’s technology position and at the same time execute on a mission for "purpose-led innovation", developing disruptive business models for not just profits, but for sustainability, where future leaders will need purpose in their hearts, not just their heads, as they develop the next generation of products for humanity.

On this show we will hear from Dr. Remmers about:

His background, how he became interested in science, in chemistry, and ultimately how he worked his way into the leadership roles of some of the world's largest chemical and pharma companies. His experience/learnings/contrasts between the pharmaceuticals business and the chemicals business. The importance of AI/data management in the development of new chemical products and holistic nutrition such as in the case of DSM’s "personalized nutrition platform". The topic of “Aging in Place” from a chemicals industry perspective and how the development of materials that are lighter, stronger and more durable, can enhance the ability of the elderly to live in their own homes and communities safely, independently, and comfortably. About the role of sustainability in a purpose-led, innovation focused organization.

This interview is in American English.

Credits: Ira Pastor interview video, text, and audio.

Follow Ira Pastor on Twitter: @IraSamuelPastor

If you liked this interview, read our interview with the CEO of BlueNalu, who use biotech to create sustainable food resources.

Follow ideaXme on Twitter: @ideaxm On Instagram: @ideaxme

Find ideaXme across the internet including on iTunes, SoundCloud, Radio Public, TuneIn Radio, I Heart Radio, Google Podcasts, Spotify, www.radioideaxme.com and more.

ideaXme is a global podcast, creator series and mentor programme. Our mission: Move the human story forward!™ ideaXme Ltd.

Ira Pastor, ideaXme life sciences ambassador and founder of Bioquark, interviews Dr. Andrei Gudkov, PhD, DSci, pre-eminent cancer researcher who serves as Senior Vice President, Research Technology and Innovation, Chair of the Department of Cell Stress Biology, and a member of the senior leadership team for National Cancer Institute (NCI) Cancer Center Support Grant at Roswell Park Comprehensive Cancer Center.

Ira Pastor comments:

As we continue on our path through the topics of the diseases of aging and healthy longevity, we are going to take a fascinating journey upstream from many of the hallmarks and forms of damage found in aging tissues, to one of the very interesting drivers of aging processes, namely the RetroElement space (termed the "retrobiome" by our guest). The retrobiome comprises a considerable fraction of eukaryotic genome, which for a long time was overlooked as "junk DNA", but in recent years is now realized to have important influence on genome functioning, and where inappropriate activation can serve as an internal clock mechanism determining aging and chronic disease progression.

Dr. Andrei Gudkov:

Dr. Andrei Gudkov, PhD, DSci, is a pre-eminent cancer researcher who serves as Senior Vice President, Research Technology and Innovation, Chair of the Department of Cell Stress Biology, and a member of the senior leadership team for National Cancer Institute (NCI) Cancer Center Support Grant at Roswell Park Comprehensive Cancer Center. Dr. Gudkov is responsible for building on the basic and translational research strengths of the Cell Stress Biology program in DNA damage and repair, photodynamic therapy, thermal and hypoxic stress and immune modulation. Dr. Gudkov assists the President and CEO at Roswell Park in developing and implementing strategic plans for new scientific programs and to enhance collaborations in research programs with regional and national academic centers as well as with industry.

Increasing Lifespan in Humans and Dogs:

Before joining Roswell Park, Dr. Gudkov served as chair of the Department of Molecular Genetics at Lerner Research Institute, Cleveland Clinic Foundation, and Professor of biochemistry at Case Western University. He earned his doctoral degree in Experimental Oncology at the Cancer Research Center, USSR and a Doctorate of Science (D.Sci) in Molecular Biology at the Moscow State University, USSR. He has authored or co-authored 135 scientific articles and holds 27 patents. Dr. Gudkov is also a serial entrepreneur who founded Cleveland BioLabs, Inc., OncoTartis LLC and Everon Biosciences, Inc. He holds the position of Director & Chief Scientific Advisor at Panacela Labs, Inc., Chief Scientific Officer of OncoTartis LLC, Chief Scientific Officer for Everon Biosciences, Inc., Chief Science Officer at Genome Protection, Inc. and Chief Scientific Officer of Cleveland BioLabs, Inc. Andrei V. Gudkov is also on the board of Incuron LLC. Dr. Gudkov is also on the Scientific Advisory Board and author of founding concept for the Vaika program, which is a not-for-profit charitable medical research organization with a mission to extend the healthspan and lifespan of domestic animals, via a novel clinical study using aged sled dogs.

On this ideaXme episode we will hear from Dr. Gudkov about: His background and how he developed an interest in oncology, in molecular biology, in aging, and the study of the retrobiome. A history of retrobiome research in the scientific community. The concept of treating aging by counteracting intrinsic DNA damage and immunosenescence and retrobiome vaccination. His oncology/cancer research program. About the Vaika program - a clinical study in aged sled dogs in order to test whether inhibition of retrobiome will be beneficial for dogs’ healthspan and longevity.

Credits: Ira Pastor interview video, text, and audio.

Follow Ira Pastor on Twitter: @IraSamuelPastor If you liked this interview, be sure to read this interview Exploring the Human-Animal Connection for Health and Wellness!

Follow ideaXme on Twitter: @ideaxm On Instagram: @ideaxme On YouTube: ideaxme Find ideaXme across the internet including on iTunes, SoundCloud, Radio Public, TuneIn Radio, I Heart Radio, Google Podcasts, Spotify and more. ideaXme is a global podcast, creator series and mentor programme.

Our mission: Move the human story forward!™ ideaXme Ltd.

Ira Pastor, ideaXme life sciences ambassador, interviews Dr. Eric Van Gieson, Program Manager in the Biological Technologies Office (BTO) at DARPA. https://www.darpa.mil/staff/dr-eric-van-gieson

Ira Pastor Comments:

On several recent ideaXme episodes, we have spent time on different topics pertaining to human health, disease, degeneration and aging, focused on a variety of therapeutic and preventative interventions being developed in the private sector of the economy, both here in the U.S. and more broadly globally. We’ve also had representatives from various independent agencies of the United States Federal Government, the UK government (UKRI), and other foreign governmental agencies, join us to discuss many of the exciting public sector discoveries and development occurring, that possess massive trickle down benefits to the general public. For example, over the last few months ideaXme has had several guests that have worked in different roles within NASA (U.S. National Aeronautics and Space Administration) talking about how research in space, can help improve the lives of us on Earth, where topics have included the bio-dynamics of sub-orbital flight training, astrobiology on the International Space Station (ISS), and even isolation chamber training for physical / psychological dynamics pertaining to future missions back to the Moon and Mars.

DARPA:

Today, we are going to go down another very interesting related path as we are joined by an expert thought leader from the Defense Advanced Research Projects Agency (DARPA), which is an agency of the United States Department of Defense responsible for the development of emerging technologies for use by the military with a mission to make pivotal investments in breakthrough technologies for national security. Originally known as the Advanced Research Projects Agency (ARPA), the agency was created in February 1958 by President Dwight D. Eisenhower in response to the Soviet launching of Sputnik 1 in 1957. By collaborating with academic, industry, and government partners, DARPA has a mission to formulate and execute research and development projects to expand the frontiers of technology and science, often beyond immediate U.S. military requirements.

Dr. Van Gieson received his PhD in Biomedical Engineering and a Bachelor of Science degree in Chemical Engineering from the University of Virginia, and joined DARPA as a Program Manager in August 2017, with the goal of using host-based methods to mitigate the impacts of emerging disease threats. He explores epigenetic and real-time monitoring approaches that can dynamically guide healthcare decisions and therapy, and new methods of increasing patient survival in austere environments using intelligent systems partnered with local care providers. Throughout his career, Dr. Van Gieson has worked with private and inter-agency government partners to build diagnostic and healthcare solutions, an example being a novel patient transport system known as the Containerized BioContainment System, a platform that received an “R&D 100” award and is currently in use by the Departments of State and Health and Human Services. Dr. Van Gieson has published on topics ranging from genomic analysis to autonomous systems. He has also served as the chief judge on the Nokia Sensing XChallenge and as a judge on the QualComm Tricorder XChallenge on behalf of the XPrize Foundation. And most recently, Dr. Van Gieson's team at DARPA is waiting on emergency use approval (EUA), from the U.S. Food and Drug Administration (FDA) for a potential "game-changing" test, originally developed for diagnosing those who have become poisoned by chemical warfare, which may be able to detect the presence coronovirus (COVID-19) in as little as 24 hours after a person is infected, well before they come infectious, filling a major diagnostic gap worldwide.

On this episode we will hear from Dr. Van Gieson about:

His background; how he developed an interest in science, in chemical and biological engineering, and how he decided he wanted to go pursue a career at DARPA. A background of DARPA, and how a career at DARPA is structured. The novel Covid-19 test that his team has developed. The Epigenetic Characterization and Observation (ECHO) program which is building a man-portable device that analyzes an individual’s epigenetic “fingerprint.” The Electrical Prescriptions (ElectRx) program aimed at delivering non-pharmacological (electrical) treatments for pain, general inflammation, post-traumatic stress, severe anxiety, and trauma, that employ precise, closed-loop, non-invasive modulation of the patient’s peripheral nervous system. The TAILOR Artificial Intelligence (AI) system for human performance optimization.

ideaXme mission: Move the human story forward!™ ideaXme Ltd.

We are a global social education platform. A podcast on 12 networks, creator series and mentor programme. You can also find us here www.radioideaxme.com Soon much more.

Amanda Christensen, Deepfake and Media Misinformation Researcher, ideaXme guest contributor and Marketing Manager at Cubaka, interviews Ruth Ben-Ghiat, Professor of History and Italian Studies at New York University, author of Strongmen: From Mussolini to the Present and advisor to Protect Democracy.

Amanda Christensen Comments: Our relationship with social media is often conflicting. On the one hand, we're more connected than ever before, both with one another as well as with public figures, news sources, and businesses. On the other, social media has proved to be easily exploitable and even dangerous, thanks to fake news, misinformation, echo chambers, and data breaches. Recent events, such as COVID-19 and the Black Lives Matter protests, have exemplified both sides of social media. Digital communities are offering support, information, and resources to one another. Unfortunately, though, people are using these platforms to spread deadly misinformation and further societal divides, for both personal and political gain.

The multi-faced nature of social media begs many questions: who can be held accountable for the spread of misinformation? How can we prioritise objective information over clickbait and fake news? How are governments exploiting the nature of social media? Is social media changing and affecting democracy as we know it?

Ruth Ben-Ghiat:

Helping us gain insight on these issues is Ruth Ben-Ghiat, historian, author, and political and cultural commentator. She is currently Professor of History and Italian Studies at New York University, as well as serving as an advisor to Protect Democracy, an organisation formed to prevent American Democracy from declining into a more authoritarian form of government. She's authored and edited seven books and several articles, such as her 2016 CNN essay on women and the draft, which is part of the United States Army’s curriculum, and her 2017 New Yorker essay on the persistence of Fascist monuments in Italy, which sparked an ongoing international debate on the legacy and memory of Mussolini’s regime.

Her latest book, Strongmen: From Mussolini to the Present Why They Succeed. How They Fall, will be published by W.W. Norton & Company in February 2021.

On this episode we’ll hear from Ben-Ghiat about:

Her background; how she became interested in history, authoritarian leaders, fascism, propaganda, and media misinformation, mal-information and disinformation. Power tactics used by authoritarian leaders throughout history, and how these tactics are changing and potentially being aided by social media platforms. Her views on the degree of responsibility that governments and platforms have in fighting fake news and misinformation. The power of information and danger of misinformation in light of recent events such as COVID-19, the Black Lives Matter protests, and Twitter’s flagging of Trump’s tweets.

Credits: Amanda Christensen interview video, text, and audio. If you liked this interview, be sure to check out our interview with Dan Mapes on the Spatial Web: Web 3.0!

Follow ideaXme on Twitter:@ideaxm On Instagram:@ideaxme

Find ideaXme across the internet including on YouTube, iTunes, SoundCloud,Radio Public,TuneIn Radio,I Heart Radio, Google Podcasts, Spotify and more.

ideaXme is a global podcast, creator series and mentor programme. Our mission: Move the human story forward!™ ideaXme Ltd.

Ira Pastor, ideaXme life sciences ambassador, interviews Dr. Sneh Khemka, President of Population Health and vHealth at one of the largest healthcare organisations.

Ira Pastor Comments:

Population Health is a discipline that helps governments and large organizations manage the health of their populations better, primarily through infrastructure development (major IT systems), clinical data analytics, health and disease management, and ultimately primary care. Virtual Health (vHealth), also known as Telehealth, is an innovative way to connect with patients using technology and telecommunications systems, and can help significantly expands access to care and increases health equity.

Dr. Sneh Khemka:

Dr. Sneh Khemka, is President of Population Health and vHealth at one of the world's largest providers of international health benefits and services, serving more than a million members worldwide, including expatriates, local nationals, and business travelers. Dr. Khemka is responsible for managing and growing this strategically important business and has successfully deployed it in India, China, South Korea, Qatar and Dubai and further afield. Previously, Dr. Khemka was Chief Operating Officer for Advanced Oncotherapy PLC, which is involved in advanced proton therapy, and is a spin off from CERN (the European Organization for Nuclear Research - home of the Large Hadron Collider). Dr. Khemka was also Director of Healthcare Development and Global Medical Director for Bupa Group, British international healthcare provisioning and multi-insurance group, with its origins and headquarters in the United Kingdom, serving 32 million customers in 190 countries. Dr. Khemka originally trained as a surgeon, specializing in ophthalmology, with an interest in ocular oncology and he continues clinical practice as a radio doctor, where he has a popular weekly call-in show on London’s LBC 97.3FM. He also works as an expedition medic, supporting people undertaking challenges around the world.

Dr. Khemka has previously advised and acted for a number of private equity houses in the UK and Europe. He is also a non-executive director of Viapath, the largest UK pathology company; acting member of the Council on the Future of Healthcare to the World Economic Forum, and previously Non-Executive Director for the Joint Commission International, the US-based leading hospital accreditation authority. In 2013, Dr. Khemka was awarded an honorary Membership to the Faculty of Public Health in recognition of his contributions to the field.

On this ideaXme episode we will hear from Dr. Khemka about:

His background and views on the resurgence of primary care in improving and maintaining long-term wellness. His views on the sustained digital change in healthcare and the new paradigm known a "phygital" (a physical/digital merging) for primary care. His thoughts on the future of online versus offline hospitals. Examples of how vHealth can be used for remote doctor consultations, arrange blood tests at home, doorstep delivery of medicines, specialist appointments and minor treatment at home. His views on the Internet Medical Things (IoMT) and Internet of Healthcare Things (IoHT). His views on vHealth in an era of Covid-19.

Credits: Ira Pastor interview video, text, and audio.

Follow Ira Pastor on Twitter:@IraSamuelPastor If you liked this interview, be sure to check out our interview on the use of Microsoft AI for good in healthcare!

Follow ideaXme on Twitter:@ideaxm On Instagram:@ideaxme Find ideaXme across the internet including on YouTube, iTunes,SoundCloud,Radio Public,TuneIn Radio,I Heart Radio, Google Podcasts, Spotify and more.

ideaXme is a global podcast, creator series and mentor programme. Our mission: Move the human story forward!™ ideaXme Ltd.

Ira Pastor, ideaXme life sciences ambassador and founder of Bioquark, interviews Dr. Christine Moutier, MD, Chief Medical Officer, at the American Foundation for Suicide Prevention (AFSP).

Ira Pastor comments: According to the World Health Organization (WHO), close to 800,000 people die due to suicide every year, which is one person every 40 seconds. Suicide is a global phenomenon and occurs throughout the lifespan, and there are indications that for each adult who died by suicide, there may have been more than 20 others attempting suicide. According to the U.S. Centers for Disease Control and Prevention (CDC) "Leading Causes of Death Report", in 2017 suicide was the tenth leading cause of death overall in the United States, claiming the lives of over 47,000 people; Suicide was the second leading cause of death among individuals between the ages of 10 and 34, and the fourth leading cause of death among individuals between the ages of 35 and 54. There were more than twice as many suicides in the United States as there were homicides. Aiding Suicide Prevention Through Psychiatry Dr. Christine Moutier, MD is the Chief Medical Officer at the American Foundation for Suicide Prevention. Dr. Moutier earned her medical degree and training in psychiatry at the University of California, San Diego, and has been a practicing psychiatrist, professor and dean in the UCSD School of Medicine, medical director of the Inpatient Psychiatric Unit at the VA Medical Center in La Jolla, and has been clinically active with diverse patient populations, such as veterans, Asian refugee populations, as well as physicians and leaders with mental health conditions. She also served as co-investigator for the Sequenced Treatment Alternatives to Relieve Depression study (STAR*D), a large National Institute of Mental Health (NIMH) trial on the treatment of refractory depression.

Dr. Christine Moutier’s Career in Psychiatry 

Dr. Moutier has authored numerous articles and book chapters for publications such as the Journal of the American Medical Association, Academic Medicine, the American Journal of Psychiatry, the Journal of Clinical Psychiatry, Psychiatric Times, Depression and Anxiety, and Academic Psychiatry. She has testified before the U.S. Congress and spoken at the White House, she was the host of AFSP’s documentary on surviving suicide loss, The Journey, and has appeared as an expert in The New York Times, The Washington Post, Time magazine, The Economist, The Atlantic, the BBC, NBC, CNN and other print and television outlets. She is also a member of the National Academy of Medicine (NAM) Action Collaborative on Clinician Well-Being and Resilience.

On this episode we will hear from Dr. Moutier about:

Her background and how she got interested in medicine, in psychiatry, and became a thought leader in the area of suicide prevention. The American Foundation for Suicide Prevention (AFSP). The top 10 learnings of why so many people are dying by suicide in 2020. The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) collaborative study on the treatment of recalcitrant depression, a leading driver of suicide. Suicide connections to modern stressors/traumas such as the Coronavirus pandemic. Nutritional interventions to help prevent depression related suicide. The National Academy of Medicine's Action Collaborative on Clinician Well-Being and Resilience and the understandings of challenges related to clinician well-being, stress and burnout, and suicide.

This interview is in American English

Credits: Ira Pastor interview video, text, and audio.

Follow Ira Pastor on Twitter: @IraSamuelPastor If you liked this interview, be sure to check out our interview with Dr. Ekaterina Malievskaia!

Follow ideaXme on Twitter: @ideaxm On Instagram: @ideaxme On YouTube: ideaxme Find ideaXme across the internet including on iTunes, SoundCloud, Radio Public, TuneIn Radio, I Heart Radio, Google Podcasts, Spotify and more. ideaXme is a global podcast, creator series and mentor programme. Our mission: Move the human story forward!™ ideaXme Ltd.

Ira Pastor, ideaXme life sciences ambassador, interviews Tom Lawry, National Director for Artificial Intelligence - Health & Life Sciences at Microsoft.

Ira Pastor Comments:

A set of tools that we have been hearing quite a bit about (and discussed a bit on the show) in recent years is the triad of artificial intelligence, machine learning, and deep learning and their respective applications (primarily in the drug discovery and development processes), in terms how university labs and startups are using some of these tools to better guide the rational drug design process, or more appropriately select patients for a clinical trial, per the field of personalized medicine.

Today, we are going to go to the far end of the spectrum, to a view of the potential of these tools at "scale", when they need to be deployed across the mega enterprises responsible for delivery quality, next generation healthcare to millions of customers.

Tom Lawry:

Tom Lawry is National Director for Artificial Intelligence - Health & Life Sciences at Microsoft. In this role he serves as a strategic advisor to provider, payer and life science organizations across the Americas, creating enterprise-wide AI initiatives designed to transform healthcare at scale. He focuses on technological, process and cultural redesign leading to the creation of Intelligent Health Systems that better empower patients, consumers and clinicians. Mr. Lawry has also served as Director of Worldwide Health for Microsoft where he worked with a similar portfolio of organizations in planning and implementing innovative analytical solutions to improve the quality and efficiency of health services delivered around the globe. Mr. Lawry focuses on strategies for digital transformation applied to performance optimization including artificial intelligence (AI), machine learning (ML) and Natural Language Processing (NLP). He previously served as Director of Organizational Performance for Microsoft’s health incubator (the Health Solutions Group). Prior to Microsoft Mr. Lawry served as a Senior Director at GE Healthcare with global responsibilities for revenue cycle management analytics and operational performance solutions. Mr. Lawry was also the founder and CEO of Verus, a U.S.-based healthcare software company named as one of the Top 100 Fastest Growing Washington Companies for three consecutive years and to the Deloitte Fast 500 Technologies list. For fourteen years Mr. Lawry served in various executive management roles in hospitals and integrated delivery networks in the United States and has published over 30 articles on topics relating to use technology and software to innovate healthcare. Most recently in February 2020 Mr. Lawry has published “AI in Health: A Leader’s Guide to Winning in the New Age of Intelligent Health Systems.”

On this episode we will hear from Mr. Lawry:

About his background in the field of health and information technologies. The healthcare "data tsunami" we have upon us in 2020 and why now is the right time for AI tools. About the "hype cycle" surrounding certain aspects of AI. The principle of AI being a "force for good" in the world. How Microsoft is leading the industry in creating a set of human-centered principles to guide the ethical creation and use of AI. About the future of the AI-human partnership. The important requirements for employees to "skill-up" for an AI-powered world. The role of the small start-up AI innovator as a partner with the large company which can "drive at scale." About futuristic areas he is most excited about, looking 10-20 years ahead, such as biohacking, mind-computer interfaces, and intelligence testing.

Credits: Ira Pastor interview video, text, and audio. Follow Ira Pastor on Twitter: @IraSamuelPastor Follow ideaXme on Twitter: @ideaxm

On Instagram:@ideaxme Find ideaXme across the internet including on iTunes,SoundCloud,Radio Public,TuneIn Radio,I Heart Radio, YouTube, Google Podcasts, Spotify and more.

ideaXme is a global podcast, creator series and mentor programme. Our mission: Move the human story forward!™ ideaXme Ltd.

Amanda Christensen, ideaXme guest contributor, fake news and deepfake researcher and Marketing Manager at Cubaka, interviews Dan Mapes, PhD, MBA co-founder of VERSES.io and co-author of The Spatial Web: How Web 3.0 Will Connect Humans, Machines, and AI to Transform the World.

Amanda Christensen Comments:

We've come a long way since the invention of the internet, and even further since the invention of the first computer, which together have undeniably significantly facilitated everyday life. We have never had access to more information at the touch of our fingers, or been more connected than we are now. However, the exponential advancement of the internet has brought along with it a whole host of problems, such as the rampant spread of fake news, deep fake technology, significant data breaches, and hacking, to name a few. The further advancement of the internet, and particularly AI, in inevitable, as the full potential of their capabilities are far from being reached. But how do we advance in a way that both further optimises our lives but simultaneously protects us from further misuse?

The Spatial Web Dan Mapes is the Co-Founder of VERSES.io, Spatial Intelligence Systems integrating Mixed Reality, Artificial Intelligence and Blockchain technology that together build The Spatial Web. Mapes, alongside Verses co-founder Gabriel René, wrote the #1 international Best Seller.

The Spatial Web:

How Web 3.0 Will Connect Humans, Machines, and AI to Transform the World, giving an in-depth understanding of the challenges and limitations with our current world wide web, such as fake news, hacking, and surveillance capitalism, as well as the wealth of practical applications of the new spatial web on personal, business, local and global levels. Crucially, Mapes stresses the importance of ensuring that there are proper standards, protocols, and legislation to ensure the spatial web operates in line with ethical and social codes.

"Creating the Spatial Web will take a significant amount of dialogue, development, and commitment from engineers, creators, thought leaders, non-profits, standards groups, and governments. To assist in creating awareness, advocacy, and adoption of Spatial Web standards, we the authors and our associates have established the VERSES Foundation, a non-profit organization dedicated to delivering the protocols and specifications needed for an open, free, and secure Spatial Web". Dan Mapes, The Spatial Web: How Web 3.0 Will Connect Humans, Machines, and AI to Transform the World

Mapes is also the Founder and CEO of Cyberlab 9, a Global Deep Tech Lab with offices in California, China and Holland, which has a focus on the Internet of Things, Blockchain, Virtual Reality and AI. As CEO of Cyberlab, he has led projects with the UN, UNDP, UNESCO, Nobel Committee, Asia-Pacific Economic Cooperation, Gorbachev Foundation, Obama Campaign and produced the First Summit Meeting on the Internet between Nelson Mandela and Shimon Peres. He has also been a technology advisor to the governments of China, Brazil, Chile, Philippines, Saudi Arabia and Australia. He has been a New Media consultant to Apple, Intel, Shanghai Media and other technology and entertainment companies.

On this episode you will hear from Dan:

A history of internet technology and its exponential advancements. How he developed an interest in Artificial Intelligence and gamification. An introduction to the spatial web and its numerous applications in optimising our world, securing our data, and revolutionising supply chains. The importance of proper protocol and regulation of the spatial web in light of fake news, data breaches, and rogue actors.

Credits: Amanda Christensen interview video, text and audio. If you liked this interview, be sure to check out our interview on filtering history's bias with neural networks!

Follow ideaXme on Twitter:@ideaxm On Instagram:@ideaxme Find ideaXme across the internet including on iTunes, YouTube, SoundCloud,Radio Public,TuneIn Radio,I Heart Radio, Google Podcasts, Spotify and more.

ideaXme is a global podcast, creator series and mentor programme.

Our mission: Move the human story forward!™ ideaXme Ltd.